Ryanodine antagonizes the effects of cardiac glycosides on contractility and abolishes digitalis-induced ventricular arrhythmias in mammalian models.
No takes yet. Share an insight, caveat, or question.
Does not support clinical use; leaves open targeted ryanodine receptor modulation for digitalis arrhythmias in future models.
Hajdu et al. (1961) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: